Publicaciones en las que colabora con Joaquín Fra Rodríguez (8)

2013

  1. Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictiv

    Mutagenesis, Vol. 28, Núm. 1, pp. 39-48

2010

  1. Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: Study based on experience at the Hospital Universitario Central de Asturias

    Clinical and Translational Oncology, Vol. 12, Núm. 8, pp. 562-567

2007

  1. Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): Results of a prospective randomized study

    Lung Cancer, Vol. 55, Núm. 2, pp. 173-180

2006

  1. Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

    Investigational New Drugs, Vol. 24, Núm. 3, pp. 241-248

2003

  1. Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: A dose-finding study

    Breast Cancer Research and Treatment, Vol. 80, Núm. 3, pp. 257-265

  2. Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

    Annals of Oncology, Vol. 14, Núm. 11, pp. 1640-1647

2002

  1. Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer

    Investigational New Drugs, Vol. 20, Núm. 3, pp. 317-326

  2. Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer

    Investigational New Drugs, Vol. 20, Núm. 1, pp. 73-82